Dr. Michael Amoashiy, MD

Dr. Amoashiy practices at Neurological Care in Brooklyn, New York.

Dr. Amoashiy's NPI, 1346354982, was assigned on August 19, 2006. Dr. Amoashiy graduated from Nicolae Testemitanu State University of Medicine and Pharmacy in 1980. Dr. Amoashiy's New York license number on file is 211960.

Dr. Amoashiy's primary practice is Neurological Care, at 408 Jay St, Brooklyn, NY 11201 in Kings County. The practice phone is (845) 634-6500.

Dr. Amoashiy's primary practice is Neurological Care in Brooklyn, New York. The medical group on file is Personal Health Imaging. Dmand AI also links Dr. Amoashiy to 1 more physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Amoashiy practices. Vendor and product names are available with a free account.

Neurology is Dr. Amoashiy's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Amoashiy is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Amoashiy's licenses on file in 4 states: New York, Florida, New Jersey and Connecticut.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, epilepsy, essential tremor, fibromyalgia and chronic pain and lower back pain among the conditions Dr. Amoashiy treats.

CMS data shows 80,074 Medicare services from Dr. Amoashiy across 28 procedure codes in 2024, for 786 Medicare patients. Medicare paid $1,002,546 for them. Every service was in an office.

CMS counts 786 Medicare patients who saw Dr. Amoashiy in 2026. The largest group is 65 to 74, with 288 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 70% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Amoashiy's median patient age at 64, with 71% women.

In 2026, Dr. Amoashiy wrote 13,967 Medicare Part D claims for 1,054 patients. 76% of them were for generic drugs. CMS names the drug for 13,475 of them, across 131 drugs with 11 or more claims each, at $4,782,500 in total drug cost. In 2023, CMS named 12,933 claims across 133 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Amoashiy for performance year 2026, reported as part of a group. Dr. Amoashiy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Amoashiy as offering telehealth.

Dmand AI links 2 papers to Dr. Amoashiy, published from 2021 to 2022. Dr. Amoashiy's most frequent co-authors are Gloria Chia-Yi Chiang, MD, Jana Ivanidze, MD, PhD and Dale J. Lange, MD.

CMS Open Payments shows 2,669 general payments to Dr. Amoashiy from 85 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $4,401.

Dr. Amoashiy graduated from Nicolae Testemitanu State University of Medicine and Pharmacy in 1980.

Dr. Amoashiy is in network with 15 carriers, including Aetna, MVP Health Care and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.